Understanding Drug Response Dynamics in BRAF-mutated Melanoma Cells
Targeted therapy is an effective standard of care in BRAF-mutated malignant melanoma. However, tumor remission varies unpredictably among patients and relapse is almost inevitable. Surprisingly, most of our current knowledge of tumor recurrence is derived from post-resistant tumor analyses, or singl...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | en |
| Published: |
VANDERBILT
2018
|
| Subjects: | |
| Online Access: | http://etd.library.vanderbilt.edu/available/etd-11212017-220336/ |